19.06.2013 Views

INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Introduction<br />

RESULTADOS<br />

Advanced glycation end products (AGEs) are molecules that appear in plasma<br />

and tissues and are generated by nonenzymatic glycation and oxidation of<br />

proteins because of the Maillard reaction, which is driven by oxidative stress in its<br />

final step 72 . In the setting of chronic heart failure (CHF), excess free-radical<br />

generation leads to increased plasma levels of AGEs 268 . There is accumulating<br />

evidence that an interaction of AGEs with their receptor (RAGE) causes activation<br />

of intracellular signaling 269 , gene expression, and production of proinflammatory<br />

cytokines and free radicals, thus playing a central role in the pathogenesis of<br />

vascular and heart complications 270 . Biological function of the soluble form of<br />

RAGE (sRAGE) has not been clearly defined and its biological importance within<br />

the AGE-RAGE axis is only recently beginning to be understood 271,272 .<br />

In the present study, we sought to evaluate the relation of sRAGE to severity and<br />

prognosis of CHF and to analyze whether this parameter has an additional value<br />

in predicting outcomes compared to the widely accepted Seattle Heart Failure<br />

Score (SHFS) 267 . SHFS is a model used to predict CHF prognosis in outpatients<br />

that uses common CHF clinical risk predictors and incorporates the effects of<br />

medical therapy and device interventions. However, the model does not<br />

incorporate certain HF prognostic parameters such as renal function 273 , B-type<br />

natriuretic peptide levels (BNP) 274 , and other biomarkers.<br />

Methods<br />

a) Study population<br />

One hundred six consecutive outpatients with stable CHF who visited our hospital<br />

(cardiology department of University Hospital of Santiago de Compostela) from<br />

September 008 through March 2009 were entered in this prospective study.<br />

Causes of CHF were identified as hypertensive in 34%, ischemic in 33%, valvular<br />

in 9%, and other in 24%. Diagnosis of CHF was based on clinic symptoms and<br />

signs and evidence of structural and/or functional cardiac abnormalities (according<br />

91

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!